These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1713806)

  • 1. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies.
    Miles SA
    Cancer Invest; 1991; 9(2):229-38. PubMed ID: 1713806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
    Miles SA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.
    Miles SA; Golde DW; Mitsuyasu RT
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):267-80. PubMed ID: 2022593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
    Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
    Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic growth factors in AIDS.
    Groopman JE; Feder D
    Semin Oncol; 1992 Aug; 19(4):408-14. PubMed ID: 1380730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P
    AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
    Miles SA; Lee K; Hutlin L; Zsebo KM; Mitsuyasu RT
    Blood; 1991 Dec; 78(12):3200-8. PubMed ID: 1720698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
    J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hematopoietic hormones for bone marrow defects in AIDS.
    Aboulafia DM
    Oncology (Williston Park); 1997 Dec; 11(12):1827-34, 1839, 1843-4; discussion 1. PubMed ID: 9436189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of GM-CSF in AIDS.
    Scadden DT
    Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    Am J Clin Oncol; 1991; 14 Suppl 1():S40-4. PubMed ID: 2048563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus.
    Mitsuyasu RT
    Rev Infect Dis; 1991; 13(5):979-84. PubMed ID: 1720567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical potential of GM-CSF in HIV-infected patients: Studies at the Memorial Sloan Kettering Cancer Center.
    Krown SE; Paredes J; Gold JW; Bundow D; Anselmo W; O'Boyle K; Flomenberg N
    Pathol Biol (Paris); 1992 Nov; 39(9):963. PubMed ID: 1538955
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine use in the management of HIV disease.
    Scadden DT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S23-9. PubMed ID: 9389312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic toxicity of zidovudine in HIV-infected patients.
    Brogan KL; Zell SC
    Am Fam Physician; 1990 May; 41(5):1521-8. PubMed ID: 1692180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
    Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
    Davey RT; Davey VJ; Metcalf JA; Zurlo JJ; Kovacs JA; Falloon J; Polis MA; Zunich KM; Masur H; Lane HC
    J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
    AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
    Fleischman RA
    Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.